Toxicity Study of CKD-602, a Camptothecin Anticancer Agent: 5-Day Repeated Intravenous Administration in Rats |
Han, Jung-Hee
(Korea Institute of Toxicology, KRICT)
Cha, Shin-Woo (Korea Institute of Toxicology, KRICT) Kim, Choong-Yong (Korea Institute of Toxicology, KRICT) Lee, Gab-Soo (Korea Institute of Toxicology, KRICT) Suh, Jeong-Eun (Korea Institute of Toxicology, KRICT) Kim, Joon-Kyum (Medicinal Research Center, Chong Kun Dang Co.) Kim, Jong-Choon (College of Veterinary Medicine, Chonnam National University) Kang, Boo-Hyon (Korea Institute of Toxicology, KRICT) |
1 | Moore, B.G., Schwartz, H.S., and Hodo, H. (1970). Inhibition of macromolecular synthesis in L1210 ascites tumor cells. J. Cell. Bioi., 47, 144A |
2 | NRC (National Research Council) (1996). Guide for the Care and Use of Laboratory Animals. National Academy, Washington. Pizzolato, J.E and Saltz, L.B. (2003). The camptothecins. Lancet, 361, 2235-2242 DOI ScienceOn |
3 | Pizzolato, J.F. and Saltz, L.B. (2003). The camptothecins. Lancet, 361, 2235-2242. DOI ScienceOn |
4 | Pratesi, G., Tortoreto, M., Corti, C., Giardini, R. and Zunino, F. (1995). Successful local therapy with topotecan of intraperitoneally growing human ovarian carcinoma xenografts. Br. J. Cancer, 71, 525-528 DOI ScienceOn |
5 | Prijovich, Z.M., Chen, B.M., Leu, Y.L., Chern, J.W. and Roffler, S.R. (2002). Anti-tumor activity and toxicity of the new prodrug 9-aminocamptothecin glucuronide (9ACG) in mice. Br. J. Cancer, 86, 1634-1638 DOI ScienceOn |
6 | Schaeppi, R.W., Fleischman, R.W. and Cooney, D.A. (1974). Toxicity of Camptothecin (NSC-100880). Cancer Chemother. Rep., 5, 25-36 |
7 | Wall, M.E., Wani, M.C. and Cook, C.E. (1966). Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata. J. Am. Chem. Soc., 88, 3888-3890 DOI |
8 | Kang, B. H., Son, H. Y., Ha, C. S., Lee, H. S. and Song, S. W.(1995). Reference values of hematology and serum chemistry in Ktc: Sprague-Dawley rats. Korean J. Lab. Ani. Sci., 1, 141-145 |
9 | Kurita, A., Kado, S., kaneda, N., Onoue, M., Hashimoto, S. and Yokokura, T. (2000). Modified irinotecan hydrochloride (CPT-11) administration schedule improves induction of delayedonset diarrhea in rats. Cancer Chemother Pharmacal., 46, 211-220 DOI ScienceOn |
10 | Wolford, S. T., Schroer, R. A., Gohs, F. X.., Gallo, P. P., Brodeck, M., Falk, H. B., and Ruhren, F. R. (1986). Reference range data base for serum chemistry and hematology values in laboratory animals. J. Toxicol. Environ. Health 18, 161-188 DOI ScienceOn |
11 | Lee, J.H., Lee, J.M., Kim, J.K., Ahn, S.K., Lee, S.J., Kim, M.Y., Jew, S.S., Park, J.G. and Hong, C.I. (1998). Antitumor activity of 7-[2-(N-isopropylamino)ethyl]-(20S)-camptothecin, CKD-602, as a potent DNA topoisomerase I inhibitor. Arch. Pharm. Res., 21, 581-590 DOI ScienceOn |
12 | Han, J., Kim, J.C., Chung, M.K, Kim, B. and Choi, D.R. (2003). Subacute toxicity and toxicokinetics of a new antibiotic, DW-224a, after single and 4-week repeated oral administration in dogs. BioI. Phann. Bull., 26, 832-839 DOI ScienceOn |
13 | Hertzberg, R.P., Caranfa, M.J., Holden, K.G., Jakas, D.R, Gallagher, G., Mattern, M.R., Mong, S.M., Bartus, J.D., Johnson, R.K and Kingsbury, W.D. (1989). Modification of the hydroxy lactone ring of camptothecin: Inhibition of mammalian topoisomerase I and biological activity. J. Med. Chem., 32, 715-720 DOI |